piperazine has been researched along with thiazoles in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fotsch, C; St Jean, DJ | 1 |
| Ardestani, SK; Behrouzi-Fardmoghadam, M; Emami, S; Foroumadi, A; Poorrajab, F; Shafiee, A | 1 |
| Berger, R; Chen, Z; Edmondson, SD; Hansen, AR; Harper, B; Holt, TG; Hubert, J; Lee, SJ; Macneil, DJ; Pan, J; Qian, S; Reitman, ML; Strack, AM; Weber, AE; Weingarth, DT; Wolff, M; Zhu, C | 1 |
| Behnke, CA; Igaki, S; Kawamura, T; Kiyota, Y; Kono, M; Kori, M; Matsumoto, T; Miyazaki, J; Nishimura, A; Oki, H; Shimojo, M | 1 |
| Adam, S; Krishna Reddy, RC; Raju, CN; Rasheed, S; Subba Rao, D; Venkata Rami Reddy, Y | 1 |
| Lakshmana, MK; Nefzi, A; Wang, H; Wang, R | 1 |
| Bender, C; Berk, B; Biltekin, SN; Bülbül, EF; Demirayak, Ş; Ertas, M; Sahin, Z; Yurttaş, L | 1 |
| Buemi, MR; De Luca, L; Fais, A; Germanò, MP; Gitto, R; Mirabile, S; Pintus, F; Rapisarda, A; Vittorio, S | 1 |
1 review(s) available for piperazine and thiazoles
| Article | Year |
|---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
7 other study(ies) available for piperazine and thiazoles
| Article | Year |
|---|---|
Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Furans; Leishmania major; Macrophages; Mice; Molecular Structure; Nitrogen Compounds; Piperazine; Piperazines; Structure-Activity Relationship; Thiazoles | 2008 |
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
Topics: Animals; Anti-Obesity Agents; Benzodiazepines; Chemokines, CC; Humans; Indoles; Methylamines; Mice; Obesity; Piperazine; Piperazines; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Thiazoles | 2008 |
Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors.
Topics: Amidohydrolases; Analgesics; Animals; Humans; Mice; Molecular Docking Simulation; Pain; Piperazine; Piperazines; Rats; Structure-Activity Relationship; Thiazoles; Urea | 2013 |
New urea and thiourea derivatives of piperazine doped with febuxostat: synthesis and evaluation of anti-TMV and antimicrobial activities.
Topics: Anti-Infective Agents; Antiviral Agents; Bacterial Physiological Phenomena; Febuxostat; Piperazine; Piperazines; Thiazoles; Thiourea; Tobacco Mosaic Virus; Urea | 2013 |
Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents.
Topics: Amyloid beta-Peptides; Animals; Benzamides; Cell Death; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Mice; Molecular Conformation; Oxidation-Reduction; Piperazine; Piperazines; Structure-Activity Relationship; Thiazoles | 2014 |
Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Donepezil; Humans; Models, Molecular; Molecular Docking Simulation; Piperazine; Thiazoles | 2018 |
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety.
Topics: Agaricales; Antioxidants; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; HeLa Cells; Humans; Molecular Structure; Monophenol Monooxygenase; Piperazine; Structure-Activity Relationship; Sulfonic Acids; Thiazoles | 2020 |